Provided by Tiger Trade Technology Pte. Ltd.

Cabot

80.65
-2.0600-2.49%
Post-market: 80.650.00000.00%19:30 EDT
Volume:358.25K
Turnover:29.00M
Market Cap:4.16B
PE:22.67
High:81.91
Open:81.47
Low:80.50
Close:82.71
52wk High:94.53
52wk Low:58.33
Shares:51.62M
Float Shares:50.93M
Volume Ratio:1.18
T/O Rate:0.70%
Dividend:1.82
Dividend Rate:2.26%
EPS(TTM):3.56
EPS(LYR):6.02
ROE:13.35%
ROA:8.90%
PB:2.59
PE(LYR):13.40

Loading ...

Cabot Corporation to Announce Third Quarter Fiscal 2026 Operating Results

GlobeNewswire
·
Jul 10

Is Cabot (CBT) Cheap On Russell Index Removals And Reinforcement Materials Risks?

Simply Wall St.
·
Jul 07

Up & Down Wall Street: There's Big Money to be Made in European Real Estate

Dow Jones
·
Jun 27

There's Big Money to be Made in European Real Estate

Dow Jones
·
Jun 26

Cabot Corp is Maintained at Neutral by Mizuho

Dow Jones
·
Jun 26

Cabot Corp : Mizuho Raises Target Price to $90 from $80

THOMSON REUTERS
·
Jun 25

U.S. Research Roundup-caseys General Stores, Micron Technology, SAP

Reuters
·
Jun 25

Cabot launches 2026 sustainability report

Reuters
·
Jun 23

Cabot Corporation Releases 2026 Sustainability Report Demonstrating Continued Progress on Sustainability Priorities

GlobeNewswire
·
Jun 23

Cabot (CBT) Stock Could Be 7.2% Overvalued After Sixth Straight EcoVadis Platinum Rating

Simply Wall St.
·
Jun 22

3 US Dividend Stocks With Balance Sheet Strength And Payout Growth

Simply Wall St.
·
Jun 20

Is Cabot’s (CBT) Elite ESG Status Quietly Reshaping Its Long-Term Competitive Position?

Simply Wall St.
·
Jun 19

Cabot earns sixth straight EcoVadis platinum ESG rating

Reuters
·
Jun 18

Cabot Corporation Earns EcoVadis Platinum Rating for Sixth Consecutive Year

GlobeNewswire
·
Jun 18

Cabot Corp Initiated at Buy by Truist Securities

Dow Jones
·
Jun 09

U.S. RESEARCH ROUNDUP- Adobe, Allstate, Teleflex

Reuters
·
Jun 08

Cloudbreak Pharma Announces Final Patient Visit for 12-Month Efficacy Endpoint in Phase 3 Study of CBT-001 as a Potential Treatment for Pterygium

GlobeNewswire
·
Jun 05

Cloudbreak Reaches Key Phase 3 Milestone for First-in-Class Pterygium Drug CBT-001

TIPRANKS
·
Jun 04

Cloudbreak-B Completes Final 12-Month Endpoint Visit for CBT-001

Stock News
·
Jun 04

Does Cabot’s Cost Cuts and Dividend Hike Reshape the Bull Case for CBT?

Simply Wall St.
·
Jun 02